Exhibit 10.1


EXCHANGE AGREEMENT


 


THIS EXCHANGE AGREEMENT
(the “Agreement”) is made as of April 20, 2020 (the “Effective Date”), by and between American
BriVision (Holding) Corporation, a Nevada corporation (the “Company”) and the undersigned hereof (the “Investor”).


 


WHEREAS, pursuant
to certain Securities Purchase Agreements dated [●] (the “SPA”), the Company issued to the Investor certain
convertible promissory note for the aggregate principal amount of $[●] plus accrued interest expenses (the “Original
Note”);


 


WHEREAS, subject
to the satisfaction of the conditions set forth herein, the Company and the Investor desire to enter into a transaction (the “Exchange”)
wherein, in exchange of the Original Note, the Company shall issue to the Investor such number of shares (“Shares”)
of common stock, par value $0.001, of the Company set forth on the signature page hereof, and the Warrant (the “Warrant”)
to purchase such number shares of common stock set forth on the signature page hereof (the “Warrant Shares”)
at an initial exercise price of $5.00 per share exercisable three years after the issuance date, in the form attached hereto as
Exhibit A, the Warrant and the Shares are collectively referred to as the “Securities”).


 


NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:


 


1. Exchange; Forbearance.
The closing (the “Closing”) of the Exchange will occur on or before third Trading Day (or such later date as
the parties hereto may agree in writing) following the satisfaction or waiver of the conditions set forth herein (such date, the
“Closing Date”). From the date of this Agreement up to and through 5:00 pm Eastern Standard time on the Closing
Date, the Investor shall take no action to enforce its rights under the Original Note. On the Closing Date, subject to the terms
and conditions of this Agreement, the Investor and the Company shall exchange the Original Note for the Securities. At the Closing,
the following transactions shall occur:


 


1.1. On the Closing Date,
the Company shall issue the Shares and deliver the Warrant to the Investor. On the Closing Date, the Investor shall be deemed for
all purposes to have become the holder of record of the Shares and the Warrant, irrespective of the date the Company delivers the
Shares and Warrant to the Investor.


 


1.2. Upon receipt of
the Shares and Warrant in accordance with this Section 1.1, all of the Investor’s rights under the Original Note shall be
extinguished. Within three Trading Days of the Closing, the investor shall deliver the Original Note to the Company for cancellation.


 


1.3 It shall be a condition
to the obligation of the Investor, on the one hand, and the Company, on the other hand, to consummate the Exchange contemplated
hereunder that the other party’s representations and warranties contained herein are true and correct on the Closing Date
with the same effect as though made on such date, unless waived in writing by the party to whom such representations and warranties
are made.


 






     


     


    

 


2. Representations
and Warranties of the Company. The Company hereby represents and warrants to the Investor that:


 


2.1 Organization.
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada, with
the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
The Company is not in violation nor default of any of the provisions of its certificate of incorporation, bylaws or other organizational
or charter documents. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
and no claim, action or proceeding of any kind has been instituted in any such jurisdiction revoking, limiting or curtailing or
seeking to revoke, limit or curtail such power and authority or qualification.


 


2.2 Authorization.
This Agreement has been duly and validly authorized, executed and delivered on behalf of the Company and shall constitute the legal,
valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except
as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies. The execution, delivery and performance by the Company of this Agreement and the consummation by the Company
of the transactions contemplated hereby and thereby will not: (i) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Company is a party or by which it is bound; or (ii) result
in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky”
laws) applicable to the Company, provided Exchange Approval (as hereinafter defined) is obtained in a timely manner.


 


2.3 Valid Issuance
of the Shares and Warrant. The Shares and the Warrant when issued and delivered in accordance with the terms of this Agreement,
for the consideration expressed herein, and the Warrant Shares when issued in accordance with the terms of the Warrant, will be
duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents.


 


2.4 Compliance With
Laws. The Company has complied in all material respects with all laws, rules, and regulations applicable to it and its business,
and the Company has not received notice of any such violation.


 


2.5 Consents; Waivers.
No consent, waiver, approval or authority of any nature, or other formal action, by any person or entity, not already obtained,
other than Exchange Approval, is required in connection with the execution and delivery of this Agreement by the Company or the
consummation by the Company of the transactions provided for herein and therein.


 


2.6 Acknowledgment
Regarding Investor’s Purchase of the Shares. The Company acknowledges and agrees that the Investor is acting solely in
the capacity of arm’s length Investor with respect to this Agreement and the Exchange and the transactions contemplated hereby
and thereby and that the Investor is not: (i) an officer or director of the Company; (ii) an “affiliate” of the Company
(as defined in Rule 144 promulgated under the Securities Act); or (iii) to the knowledge of the Company, a “beneficial owner”
of 4.99% or more of the shares of Common Stock (as defined for purposes of Rule 13d-3 under the Securities Exchange Act of 1934
(the “Exchange Act”). The Company further acknowledges that the Investor is not acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to the Exchange, this Agreement, any other document or agreement
delivered in connection herewith or therewith or the transactions contemplated hereby and thereby, and any advice given by the
Investor or any of its representatives or agents in connection with the Exchange, this Agreement, any other document or agreement
delivered in connection herewith or therewith or the transactions contemplated hereby and thereby is merely incidental to the Investor’s
acceptance of the Shares. The Company further represents to the Investor that the Company’s decision to enter into the Exchange
has been based solely on the independent evaluation by the Company and its representatives.


 




    2


     


    

  


3. Representations
and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:


 


3.1. Authority.
The Investor has the full right and power to enter into and perform pursuant to this Agreement and to make an investment in the
Company, and this Agreement constitutes the Investor’s valid and legally binding obligation, enforceable in accordance with
its terms. The Investor is authorized and otherwise duly qualified to purchase and hold the Securities and to enter into this Agreement.


 


3.2. Authorization.
This Agreement has been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the
legal, valid and binding obligations of the Investor enforceable against the Investor in accordance with their respective terms,
except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies. The execution, delivery and performance by the Investor of this Agreement and the consummation by the Investor
of the transactions contemplated hereby and thereby will not: (i) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party or by which it is bound; or (ii) result
in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky”
laws) applicable to the Investor.


 


3.3.Regulation S Exemption,
Non U.S Person. The Investor understands that the Securities are being offered and sold to it in reliance on an exemption
from the registration requirements of the United States federal and state securities laws under Regulation S promulgated under
the Securities Act and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the applicability of such exemptions
and the suitability of the Investor to acquire the Securities. In this regard, the Investor represents, warrants and agrees that:


 


(1) No Investor is a
U.S. Person (as defined below). Status of Investor. The Investor is a “non-US person” as defined in Regulation S. The
Investor further makes the representations and warranties to the Company set forth on Exhibit A. Such Investor is not required
to be registered as a broker-dealer under Section 15 of the Exchange Act and such Investor is not a broker-dealer, nor an affiliate
of a broker-dealer.


 


(2) At the time of the
origination of contact concerning this Agreement and the date of the execution and delivery of this Agreement, the Investor was
outside of the United States.


 


(3) The Investor will
not, during the period commencing on the date of issuance of the Securities and ending on the end of the sixth month of such date,
or such shorter period as may be permitted by Regulation S or other applicable securities law (“Restricted Period”),
offer, sell, pledge or otherwise transfer the Securities in the United States, or to a U.S. Person for the account or benefit of
a U.S. Person, or otherwise in a manner that is not in compliance with Regulation S.


 


(4) The Investor will,
after expiration of the Restricted Period, offer, sell, pledge or otherwise transfer the Securities only pursuant to registration
under the Securities Act or an available exemption therefrom and, in accordance with all applicable state and foreign securities
laws.


 


(5) The Investor has
not in the United States, engaged in, and prior to the expiration of the Restricted Period will not engage in, any short selling
of or any hedging transaction with respect to the Securities, including without limitation, any put, call or other option transaction,
option writing or equity swap.


 






    3


     


    

 


(6) Neither the Investor
nor any person acting on the Investor’s behalf has engaged, nor will engage, in any directed selling efforts to U.S. Persons
with respect to the Securities and the Investor and any person acting on its behalf have complied and will comply with the “offering
restrictions” requirements of Regulation S under the Securities Act.


 


(7) The transactions
contemplated by this Agreement have not been pre-arranged with a buyer located in the United States or with a U.S. Person, and
are not part of a plan or scheme to evade the registration requirements of the Securities Act.


 


(8) Neither any Investor
nor any person acting on the Investor’s behalf has undertaken or carried out any activity for the purpose of, or that could
reasonably be expected to have the effect of, conditioning the market in the United States, its territories or possessions, for
any of the Securities. The Investor agrees not to cause any advertisement of the Securities to be published in any newspaper or
periodical or posted in any public place and not to issue any circular relating to the Securities, except such advertisements that
include the statements required by Regulation S under the Securities Act, and only offshore and not in the U.S. or its territories,
and only in compliance with any local applicable securities laws.


 


(9) The Investor has
engaged in any “Directed Selling Efforts in the U.S.”, as defined in Regulation S promulgated by the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”).


 


(10) The Investor
acquires the Securities solely for its own account for the purpose of investment and not with a view to or for sale in connection
with a distribution to anyone. The Investor has no present plan or intention to sell the Securities in the United States or to
a U.S. person at any predetermined time, has made no predetermined arrangements to sell the Securities and is not acting as a distributor
of such securities.


 


3.4. No Governmental
Review. The Investor understands that no United States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.


 


3.5. Ownership of
Original Note. The Investor owns and holds, beneficially and of record, the entire right, title, and interest in and to the
Original Note free and clear of all rights and Liens (other than pledges or security interests (x) arising by operation of applicable
securities laws and (y) that the Investor may have created in favor of a prime broker under and in accordance with its prime brokerage
agreement with such broker). The Investor has full power and authority to transfer and dispose of the Original Note to the Company
free and clear of any right or lien. Other than the transactions contemplated by this Agreement, there is no outstanding, plan,
pending proposal, or other right of any person or entity to acquire all or any part of the Original Note or any Securities of Common
Stock issuable upon the delivery of the Issuance Notice and corresponding deduction of the face amount of the Securities, or pursuant
to the terms of the Warrant.


 


3.6. Sophistication
and Knowledge. The Investor and/or with its representative(s) has such knowledge and experience in financial and business matters
that it can represent itself and is capable of evaluating the merits and risks of the purchase of the Securities. The Investor
is not relying on the Company with respect to the tax and other economic considerations of an investment in the Securities, and
the Investor has relied on the advice of, or has consulted with, only the Investor’s own advisor(s).


 




    4


     


    

  


3.7 Investment Experience.
Such Investor acknowledges that the investment in the Securities pursuant to this Agreement is a highly speculative investment
and that it can bear the economic risk and complete loss of such investment and has such knowledge and experience in financial
or business matters such that it is capable of evaluating the merits and risks of the investment contemplated hereby. The Investor
is not relying on the Company with respect to the tax and other economic considerations of an investment in the Securities, and
the Investor has relied on the advice of, or has consulted with, only the Investor’s own advisor(s).


 


3.8 Access to Information.
The Investor, in making the decision to purchase the Securities, has relied solely upon independent investigations made by it and/or
its representatives, if any. The Investor and/or its representatives during the course of this transaction, and prior to the purchase
of any Securities, has had the opportunity to ask questions of and receive answers from the management of the Company concerning
the terms and conditions of the offering of the Securities and to receive any additional information, documents, records and books
relative to its business, assets, financial condition, results of operations and liabilities (contingent or otherwise) of the Company.
The Investor acknowledges that it understands that the Company publishes periodic reports under the Securities Exchange Act of
1934 on the website of the Securities and Exchange Commission (the “SEC”), which can be accessed at www.sec.gov. Such
Investor has read the Company’s periodic reports available online and acknowledges that such information is sufficient for
the Investor to evaluate the risks of investing in the Securities. The Investor is not relying on any disclosures concerning the
Company made by the Company or any officer, employee or agent of the Company, other than those contained in the public reports
filed by the Company with the SEC.


 


3.9 Lack of Liquidity.
The Investor acknowledges that the purchase of the Securities involves a high degree of risk and further acknowledges that it can
bear the economic risk of the purchase of the Securities, including the total loss of its investment. The Investor has no present
need for liquidity in connection with its purchase of the Securities.


 


3.10 No Public Solicitation.
The Investor is not subscribing for the Securities as a result of or subsequent to any advertisement, article, notice or other
communication published in any newspaper, magazine or similar media or broadcast over television or radio, or presented at any
seminar or meeting, or any solicitation of a subscription by a person not previously known to the Investor in connection with investments
in securities generally.


 


3.11 Restricted Securities.


 


(1) The Investor understands
that the Securities have not been registered under the Securities Act, by reason of a specific exemption from the registration
provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the
accuracy of the Investor’s representations as expressed herein. The Investor understands that the Securities are “restricted
securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Investor must hold
the Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. The Investor acknowledges that the Company has no obligation to register
or qualify the Securities for resale. The Investor further acknowledges that if an exemption from registration or qualification
is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding
period for the Securities, and on requirements relating to the Company which are outside of the Investor’s control, and which
the Company is under no obligation and may not be able to satisfy. The Investor understands that this offering is not intended
to be part of the public offering, and that the Investor will not be able to rely on the protection of Section 11 of the Securities
Act.


 




    5


     


    

  


(2) Such
Investor acknowledges that such Investor is familiar with Rule 144 and Rule 144A, of the rules and regulations of the Commission,
as amended, promulgated pursuant to the Securities Act (“Rule 144”), and that such person has been advised that
Rule 144 and Rule 144A, as applicable, permits resales only under certain circumstances. Such Investor understands that to the
extent that Rule 144 or Rule 144A is not available, such Investor will be unable to sell any Securities without either registration
under the Securities Act or the existence of another exemption from such registration requirement.


 


(3) Each certificate
representing the Securities and the Warrant shall be endorsed with the following legends as well as any other legend required to
be placed thereon by applicable federal or state securities laws.:


 


“THE SECURITIES
ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(“THE SECURITIES ACT”)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE
SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT. “


 


“TRANSFER OF THESE
SECURITIES IS PROHIBITED, EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT, OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
THE SECURITIES ACT. “


 


(4) The Investor consents
to the Company making a notation on its records or giving instructions to any transfer agent of the Company in order to implement
the restrictions on transfer of the Securities.


 


54. Additional Covenants


 


4.1. Blue Sky.
The Company shall make all filings relating to the Exchange required by Regulation D under the Securities Act and under applicable
securities or “blue sky” laws of the states of the United States following the date hereof.


 


4.2. Fees and Expenses.
Except as otherwise set forth in this Agreement, each party to this Agreement shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. Notwithstanding the foregoing, the Company will reimburse the Investor for
$10,000 in legal expenses upon execution of this Agreement.


 


5. Miscellaneous


 


5.1. Successors and
Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and
be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this Agreement, express
or implied, is intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any
rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.


 




    6


     


    

  


5.2. Governing Law;
Exclusive Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by the internal laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict
of law provision or rule (whether of the Commonwealth of Pennsylvania or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the Commonwealth of Pennsylvania. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state or federal courts sitting in or for Delaware County, Pennsylvania, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action
or proceeding is improper. Each of the parties hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum.


 


5.3. Notices.
All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently
given if delivered to the addressees in person, by FedEx or similar overnight next Trading Day delivery, or by email followed by
overnight next Trading Day delivery, to the address as provided for on the signature page to this agreement.


 


5.4. Amendments and
Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Investor.


 


5.5. Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms so long as this Agreement as so modified continues to express, without material change, the original
intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)
in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close
as possible to that of the prohibited, invalid or unenforceable provision(s).


 


5.6. Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.


 


5.7. Survival.
The representations, warranties and covenants of the Company and the Investor contained herein shall survive the Closing and delivery
of the Shares.


 


6. Definitions.
For purposes of this Agreement, the following words and terms shall have the following meanings:


 


6.1 “Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.


 






    7


     


    

 


6.2. “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.


  


6.3. “Principal
Market” means any of The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Select
Market, the Nasdaq Global Market, the OTCQB, the OTCQX, the OTC Pink or any other market operated by the OTC Markets Group Inc.
or any successors of any of these exchanges or markets.


 


6.4. “Trading
Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock,
any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market
for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,
provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange
or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on
such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange
or market, then during the hour ending at 4:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in
writing by the Investor or (y) with respect to all determinations other than price determinations relating to the Common Stock,
any day on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.


 


6.5. “Transaction
Documents” means this Agreement, the Shares and all exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder.


 


[SIGNATURES ON THE FOLLOWING PAGE]


  




    8


     


    

   


IN WITNESS WHEREOF, the parties
have caused this Agreement to be duly executed and delivered as of the date provided above.


 


	 	COMPANY:
	 	 
	 	American BriVision (Holding) Corporation 
	 	 
	 	By: 	/s/ Chihliang An
	 	 	Name: Chihliang An 
	 	 	Title: Chief Financial Officer 
	 	 
	 	Address for Notices: 
	 	 
	 	44370 Old Warm Springs Blvd.
	 	Fremont, CA 94538


 




     


     


    

  


IN WITNESS WHEREOF, the parties have caused
this Agreement to be duly executed and delivered as of the date provided above.


 


	 	INVESTOR: 
	 	 
	 	[●]
	 	 
	 	By: 	                            
	 	 	Name: [●]
	 	 	Title: [●]
	 	 
	 	
        Principal Amount of the Original Note: __________

         

        Number of Shares of Common Stock to be received:____________1

         

        Warrant to Purchase such number of share of Commons Stock: __________
        2

	 	
          

        Address for Notices:

	 	 
	 	 
	 	 
	 	 


 


 



1 The number
of Shares shall be the principal amount of the Original Note divided by 70% of the average OTC closing price for the 15 trading
days preceding the Closing of the Exchange.


 


2 The number
of Warrant Shares shall be the principal amount of the Original Note divided by 70% of the average OTC closing price for the 15
trading days preceding the Closing of the Exchange.






 




     


     


    

 


EXHIBT A


 


Form of Warrant